QuidelOrtho financials
$10.60−2.17%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 28 | Q1 '26 Mar 29 | Q4 '25 Dec 28 | Q3 '25 Sep 28 | Q2 '25 Jun 29 | Q1 '25 Mar 30 | Q4 '24 Dec 29 | Q3 '24 Sep 29 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Oct 1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $630.9M | $619.8M | $723.6M | $699.9M | $613.9M | $692.8M | $707.8M | $727.1M | $637.0M | $711.0M | $742.6M | $744.0M |
| Gross profit | $272.9M | $263.8M | $320.4M | $335.6M | $274.9M | $343.3M | $326.1M | $352.3M | $276.0M | $332.1M | $382.6M | $369.4M |
| Gross margin | 43.3% | 42.6% | 44.3% | 47.9% | 44.8% | 49.6% | 46.1% | 48.5% | 43.3% | 46.7% | 51.5% | 49.7% |
| Operating income | -$21.8M | -$31.8M | -$66.3M | -$704.8M | -$180.7M | $32.6M | -$100.4M | $15.0M | -$117.5M | -$1.76B | $73.1M | $52.8M |
| Net income | -$92.9M | -$91.8M | -$130.7M | -$733.0M | -$255.4M | -$12.7M | -$178.4M | -$19.9M | -$147.7M | -$1.71B | $7.0M | -$12.7M |
| Net margin | −14.7% | −14.8% | −18.1% | −104.7% | −41.6% | −1.8% | −25.2% | −2.7% | −23.2% | −239.9% | 0.9% | −1.7% |
| Diluted EPS | $-1.36 | $-1.35 | $-1.92 | $-10.78 | $-3.77 | $-0.19 | $-2.64 | $-0.30 | $-2.20 | $-25.50 | $0.11 | $-0.19 |
| EBITDA | $101.4M | $85.5M | $75.2M | $157.3M | $108.5M | $155.8M | $124.5M | $164.9M | $86.4M | $123.4M | $74.4M | $168.1M |
| Operating cash flow | -$110.6M | -$33.0M | $131.9M | -$45.5M | -$46.8M | $65.6M | $63.7M | $117.9M | -$97.9M | -$700.0K | $80.4M | $41.5M |
| Free cash flow | -$136.1M | -$67.0M | $86.6M | -$94.7M | -$84.3M | $9.4M | $16.5M | $71.4M | -$133.2M | -$66.8M | $31.8M | -$1.9M |
| Diluted shares | 68.3M | 68.2M | 68.0M | 68.0M | 67.7M | 67.5M | 67.5M | 67.3M | 67.1M | 66.9M | 66.4M | 66.9M |
Balance sheet
| Period end | Jun 28 | Mar 29 | Dec 28 | Sep 28 | Jun 29 | Mar 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $123.4M | $140.4M | $169.8M | $98.1M | $151.7M | $127.1M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.89B | $2.69B | $2.65B | $2.66B | $2.61B | $2.50B |
| Total assets | $5.72B | $5.63B | $5.77B | $5.68B | $6.38B | $6.46B |
| Total liabilities | $3.94B | $3.78B | $3.85B | $3.64B | $3.59B | $3.46B |
| Shareholders' equity | $1.77B | $1.85B | $1.92B | $2.04B | $2.79B | $3.00B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology